. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: Int J Infect Dis. 2015 Oct 24;41:13–16. doi: 10.1016/j.ijid.2015.10.012

Table 2.

HR HPV type distribution by country for normal cytology

	Guadeloupe (French West Indies)		France (Heard et al., 2013)			Developed regions (WHO/ICO 2010)			Tobago (Ragin et al., 2007)
	%	95% CI	%	95% CI	p-Value^a	%	95% CI	p-Value^a	%	95% CI	p-Value^a
HR HPV^b	25.1	21.1–29.3	13.7	11.7–15.6	<0.001	10.3	10.2–10.4	<0.001	20.6	15.3–26.8	0.192
HPV 16 and/or 18^c	5.4	3.5–7.9	3.9	2.8–5.1	0.089	3.6	3.5–3.7	0.017	2.5	0.8–5.6	0.089
HR HPV other than 16 and/or 18^d	19.7	16.1–23.7	9.7	8.0–11.4	<0.001	6.0	5.9–6.1	<0.001	18.1	13.1–24.1	0.616

HR, high-risk; HPV, human papillomavirus; WHO/ICO, World Health Organization/Institut Català d’Oncologia; CI, confidence interval.

Comparison to Guadeloupe.

At least one HR HPV type among 16, 18, and other HR types (i.e., 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68).

HPV 16 and/or 18 irrespective of other HR HPV types.

Other HR HPV types, excluding HPV 16 and 18.